These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6839631)

  • 1. Enhancement of nadolol elimination by activated charcoal and antibiotics.
    du Souich P; Caillé G; Larochelle P
    Clin Pharmacol Ther; 1983 May; 33(5):585-90. PubMed ID: 6839631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nadolol in healthy subjects.
    Schäfer-Korting M; Bach N; Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1984; 26(1):125-7. PubMed ID: 6714285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of orally coadministered nadolol and its deuterated analogue in human serum and urine by gas chromatography with selected-ion monitoring mass spectrometry.
    Cohen AI; Devlin RG; Ivashkiv E; Funke PT; McCormick T
    J Pharm Sci; 1984 Nov; 73(11):1571-5. PubMed ID: 6151597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of size and frequency of oral doses of charcoal on theophylline clearance.
    Park GD; Radomski L; Goldberg MJ; Spector R; Johnson GF; Quee CK
    Clin Pharmacol Ther; 1983 Nov; 34(5):663-6. PubMed ID: 6627827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral activated charcoal and dapsone elimination.
    Neuvonen PJ; Elonen E; Mattila MJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):823-7. PubMed ID: 7379451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H; Kubitza D; Möller JG; Delesen H
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of nadolol by patients with renal impairment.
    Herrera J; Vukovich RA; Griffith DL
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):227S-231S. PubMed ID: 37878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterohepatic recirculation of oestriol: inhibition by activated charcoal.
    Heimer GM; Englund DE
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):93-5. PubMed ID: 3766051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nadolol in human serum and breast milk.
    Devlin RG; Duchin KL; Fleiss PM
    Br J Clin Pharmacol; 1981 Sep; 12(3):393-6. PubMed ID: 6117304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the surface area of activated charcoal on theophylline clearance.
    Park GD; Spector R; Goldberg MJ; Johnson GF; Feldman R; Quee CK
    J Clin Pharmacol; 1984 Jul; 24(7):289-92. PubMed ID: 6480875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug.
    Watson WA; Jenkins TC; Velasquez N; Schentag JJ
    J Toxicol Clin Toxicol; 1987; 25(3):171-84. PubMed ID: 3612896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of adsorption effect of activated charcoal on oral paraquat poisoning: an experimental study on large animal].
    Sun B; He Y; Pei Y; Zhang C; Zhang X; Yang Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Mar; 29(3):211-215. PubMed ID: 28627339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral activated charcoal on propranolol pharmacokinetics following intravenous administration to rabbits.
    al-Meshal MA; el-Sayed YM; al-Angary AA; al-Dardiri MM
    J Clin Pharm Ther; 1993 Feb; 18(1):39-44. PubMed ID: 8473358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of exaprolol and propranolol in rats with interrupted enterohepatic circulation.
    Motheová O; Bezek S; Durisová M; Faberová V; Zemánek M; Misánikova K; Trnovec T
    Biopharm Drug Dispos; 1986; 7(2):151-62. PubMed ID: 2871875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of nadolol into aqueous humour after a single oral dose.
    Tiong TH; Hung SO; Perelman MS
    Br J Clin Pharmacol; 1988 Jul; 26(1):92-5. PubMed ID: 3203065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a once-daily oral dose of nadolol on intraocular pressure in normal volunteers.
    Rennie IG; Smerdon DL
    Am J Ophthalmol; 1985 Sep; 100(3):445-7. PubMed ID: 4037034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of digoxin clearance by activated charcoal.
    Lalonde RL; Deshpande R; Hamilton PP; McLean WM; Greenway DC
    Clin Pharmacol Ther; 1985 Apr; 37(4):367-71. PubMed ID: 3978996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.